COVID-19 Prompts OTC Sales Restrictions Across Europe
Countries across Europe are restricting sales of OTC drugs in response to COVID-19 to maintain supply and counteract stockpiling. The approach varies widely across the region: countries such as Germany and France have introduced strict limits, while others, such as the UK and Ireland, have not ordered official restrictions. HBW Insight presents an analysis of the actions taken by 14 European countries to the upsurge in demand for OTCs.
You may also be interested in...
HBW Insight extracts five key lessons from 2020, the year the coronavirus pandemic swept its way across Europe.
Europe’s self-care industry has “learned its lessons,” particularly in terms of securing the pharmaceutical ingredient supply chain, and will come out of the coronavirus pandemic stronger, insisted AESGP president Birgit Schuhbauer at the BAH’s High-Level Conference on Future Drug Supply in the European Union.
Production of paracetamol will return to France after a more than 10 year absence in an initiative spearheaded by President Macron to avoid future shortages.